EvoNext Holdings SA - Company Profile

Powered by

All the sales intelligence you need on EvoNext Holdings SA in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how EvoNext Holdings SA fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with EvoNext Holdings SA.

Back to companies

EvoNext Holdings SA: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

EvoNext Holdings SA (EvoNext) is a biotechnology company. It focuses on pursuing functional cures for rare disease patients and their families. EvoNext is headquartered in Reinach, Switzerland.

 Gain a 360-degree view of EvoNext Holdings SA and make more informed decisions for your business Gain a 360-degree view of EvoNext Holdings SA and make more informed decisions for your business Learn more
Headquarters Switzerland
Address Duggingerstrasse 23, Reinach, 4153
Website evonextholdings.com
Telephone 41 61 4852000
Industry Ingredients
Ticker Symbol & Exchange EVE (SWF)
EPS XYZ
Net Income (2023) XYZ 101% (2023 vs 2022)
Market Cap* $21.5M
Net Profit Margin (2022) XYZ -299.5% (2023 vs 2022)
   
   
* As of and is in US$
View EvoNext Holdings SA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2025 Corporate Changes/Expansions In July, the company changed its name to EvoNext Holdings SA.
2025 Plans/Strategy In May, the company announced its plans to acquire a 100% stake in GZO AG Spital Wetzikon for CHF 5 million.
2023 Stake Sale In November, the company sold 100% of the shares of Evolva AG and its subsidiaries to Danstar Ferment AG.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into EvoNext Holdings SA key executives to enhance your sales strategy Gain insight into EvoNext Holdings SA key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?